Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

IPSS-M for Transplant Decision Making of Patients with Myelodysplastic Syndromes: A Retrospective Single-Center Study

Annalisa Condorelli, Silvia Salmoiraghi, Chiara Pavoni, Matteo Raviglione, Alessia Civini, Alessandro Putelli, Marco Frigeni, Tamara Intermesoli, Federico Lussana, Giulia Quaresmini, Marta Bellini, Maria Chiara Finazzi, Orietta Spinelli, Alessandro Rambaldi

Blood (2023) 142 (Supplement 1): 6449.

https://doi.org/10.1182/blood-2023-187369

Published: 2023

Journal Articles

Improving Prediction of Early Death in Acute Promyelocytic Leukemia: External Validation Study from Italian Single Center Experience

Marco Frigeni, Leonardo Gerosa, Chiara Pavoni, Tamara Intermesoli, Giulia Quaresmini, Marta Bellini, Marta Castelli, Clara Belotti, Martina Milani, Silvia Salmoiraghi, Orietta Spinelli, Fabio Lorenzano, Alessandro Putelli, Monica Galli, Federico Lussana, Alessandro Rambaldi

Blood (2023) 142 (Supplement 1): 4232.

https://doi.org/10.1182/blood-2023-187507

Published: 2023

Journal Articles

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)

Tiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, Alessandra Iurlo, Valerio De Stefano, Marta Anna Sobas, Elisa Rumi, Elena Maria Elli, Francesca Lunghi, Mercedes Gasior Kabat, Beatriz Cuevas, Paola Guglielmelli, Massimiliano Bonifacio, Monia Marchetti, Alberto Alvarez-Larran, Laura Maria Fox, Marta Bellini, Rosa Daffini, Giulia Benevolo, Gonzalo Carreño, Andrea Patriarca, Haifa Kathrin Al-Ali, Marcio Andrade, Francesca Palandri, Claire Harrison, Maria Angeles Foncillas, Santiago Osorio, Steffen Koschmieder, Elena Magro, Jean-Jacques Kiladjian, Estefanía Bolaños, Florian H. Heidel, Keina Quiroz, Martin Griesshammer, Valentín García Gutiérrez, Alberto Marin Sanchez, Juan Carlos Hernandez Boluda, Emma Lopez Abadia, Giuseppe Carli, Miguel Sagüés, Rajko Kusec, Blanca Xicoy, Margarita Guenova, Begoña Navas, Anna Angona, Edyta Cichocka, Anna Masternak, Daniele Cattaneo, Cristina Bucelli, Silvia Betti, Oscar Borsani, Fabrizio Cavalca, Sara Carbonell, Natalia Curto-Garcia, Lina Benajiba, Alessandro Rambaldi, Alessandro M. Vannucchi

Blood (2022) 140 (Supplement 1): 6815–6818.

https://doi.org/10.1182/blood-2022-158902

Published: 2022

Journal Articles

Ropeginterferon Alfa-2b Versus Standard Therapy for Low-Risk Patients with Polycythemia Vera. Final Results of Low-PV Randomized Phase II Trial

Blood (2022) 140 (Supplement 1): 1797–1799.

https://doi.org/10.1182/blood-2022-157255

Published: 2022

Journal Articles

Training and Validation Cohorts for Predicting the Impact of High Molecular Risk Mutations after Allogeneic Stem Cell Transplantation in Myelofibrosis

Blood (2022) 140 (Supplement 1): 10622–10623.

https://doi.org/10.1182/blood-2022-162298

Published: 2022

Journal Articles

Second Versus First Wave of COVID-19 in Patients with MPN

Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli, Marta Sobas, Elena Maria Elli, Elisa Rumi, Valerio De Stefano, Francesca Lunghi, Monia Marchetti, Rosa Daffini, Mercedes Gasior Kabat, Beatriz Cuevas, Laura Maria Fox, Marcio Andrade, Francesca Palandri, Paola Guglielmelli, Giulia Benevolo, Claire N. Harrison, Maria Angeles Foncillas, Massimiliano Bonifacio, Alberto Alvarez-Larran, Jean-Jacques Kiladjian, Estefanía Bolaños, Andrea Patriarca, Keina Quiroz, Martin Griesshammer, Valentín Garcia Gutierrez, Alberto Marin Sanchez, Elena Magro, Marco Ruggeri, Juan Carlos Hernandez Boluda, Santiago Osorio, Gonzalo Carreño Gomez-Tarragona, Miguel Sagüés, Rajko Kusec, Begoña Navas, Anna Angona, Blanca Xicoy, Emma Lopez Abadia, Steffen Koschmieder, Daniele Cattaneo, Cristina Bucelli, Edyta Cichocka, Anna Masternak, Fabrizio Cavalca, Oscar Borsani, Silvia Betti, Marta Bellini, Natalia Curto-Garcia, Alessandro Rambaldi, Alessandro Vannucchi

Blood (2021) 138 (Supplement 1): 315.

https://doi.org/10.1182/blood-2021-146134

Published: 2021

Journal Articles

The Interaction between IPSS Score and JAK2 Mutation Identifies Patients at Different Vascular Risk in Primary Myelofibrosis

Blood (2021) 138 (Supplement 1): 236.

https://doi.org/10.1182/blood-2021-145116

Published: 2021

Journal Articles

Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms

Tiziano Barbui, MD, Valerio De Stefano, MD, Alessandra Carobbio, MSc, Vincenzo Di Lazzaro, MD, Paola Guglielmelli, MD PhD, Giuseppe Gaetano Loscocco, MD, Alessandra Iurlo, MD PhD, Daniele Cattaneo, MD, Agostino Cortelezzi, Prof, Silvia Betti, MD, Elena Rossi, MD, Maria Chiara Finazzi, MD, Guido Finazzi, MD, Bruno Censori, MD, Mario Cazzola, MD, Elisa Rumi, MD, Marta Bellini, MD, Francisco Cervantes, MD, Eduardo Arellano-Rodrigo, MD, Elena Elli, MD, Maria Luigia Randi, MD, Irene Bertozzi, MD, Martin Griesshammer, MD, Parvis Sadjadian, MD, Francesca Palandri, PhD MD, Nicola Vianelli, Massimiliano Bonifacio, MD, Luigi Scaffidi, Juan Carlos Hernandez-Boluda, MD, Montse Gomez, MD, Emma Cacciola, MD, Rossella Rosari Cacciola, MD, Palova Miroslava, MD, Giuseppe Carli, MD, Eloise Beggiato, MD, Martin H Ellis, MD, Caterina Musolino, MD, Gianluca Gaidano, MD PhD, Davide Rapezzi, MD, Alessia Tieghi, MD, Francesca Lunghi, MD, Alessandro M. Vannucchi

Blood (2017) 130 (Supplement 1): 202.

https://doi.org/10.1182/blood.V130.Suppl_1.202.202

Published: 2017

Journal Articles

Genomic Profiling of Blast Phase in Philadelphia-Negative Myeloproliferative Neoplasms

Elisa Roncoroni, Jelena D. Milosevic Feenstra, PhD, Elisa Rumi, MD, Daniela Pietra, PhD, Virginia Valeria Ferretti, Marta Bellini, MD, Chiara Cavalloni, MD, Ilaria Carola Casetti, MD, Roland Jäger, PhD, Edith Bogner, Michele Ciboddo, MD, Patrizia Zappasodi, MD, Cristina Picone, Laura Vanelli, Cesare Astori, MD, Robert Kralovics, PhD, Mario Cazzola, MD

Blood (2017) 130 (Supplement 1): 1652.

https://doi.org/10.1182/blood.V130.Suppl_1.1652.1652

Published: 2017

Journal Articles

LNK mutations in familial myeloproliferative neoplasms

Elisa Rumi, Ashot S. Harutyunyan, Daniela Pietra, Jelena D. Milosevic Feenstra, Chiara Cavalloni, Elisa Roncoroni, Ilaria Casetti, Marta Bellini, Chiara Milanesi, Maria C. Renna, Manuel Gotti, Cesare Astori, Robert Kralovics, Mario Cazzola

Blood (2016) 128 (1): 144–145.

https://doi.org/10.1182/blood-2016-04-711150

Published: 2016

Journal Articles

Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin

Daniela Pietra, PhD, Elisa Rumi, MD, Chiara Milanesi, BS, Christian A Di Buduo, PhD, Marta Bellini, MD, Ilaria Carola Casetti, MD, Chiara Cavalloni, MD, Emanuela Sant'Antonio, Vittorio Abbonante, PhD, Maria C Renna, BS, Virginia Ferretti, PhD, Emanuela Boveri, MD, Alessandra Balduini, MD, Cristiana Pascutto, PhD, Mario Cazzola, MD

Blood (2014) 124 (21): 3215.

https://doi.org/10.1182/blood.V124.21.3215.3215

Published: 2014

Journal Articles

Clinical effect of driver mutations of JAK2 , CALR , or MPL in primary myelofibrosis

Blood (2014) 124 (7): 1062–1069.

https://doi.org/10.1182/blood-2014-05-578435

Published: 2014

Journal Articles

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

Elisa Rumi, Ashot S. Harutyunyan, Daniela Pietra, Jelena D. Milosevic, Ilaria C. Casetti, Marta Bellini, Nicole C. C. Them, Chiara Cavalloni, Virginia V. Ferretti, Chiara Milanesi, Tiina Berg, Emanuela Sant’Antonio, Emanuela Boveri, Cristiana Pascutto, Cesare Astori, Robert Kralovics, Mario Cazzola

Blood (2014) 123 (15): 2416–2419.

https://doi.org/10.1182/blood-2014-01-550434

Published: 2014

Includes: Supplemental data

Journal Articles

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Blood (2014) 123 (10): 1544–1551.

https://doi.org/10.1182/blood-2013-11-539098

Published: 2014

Includes: Supplemental data

Journal Articles

JAK2 (V617F)-Positive Essential Thrombocythemia and Polycythemia Vera Are Different Expressions Of a Genotypic/Phenotypic Continuum

Elisa Rumi, MD, Daniela Pietra, PhD, Chiara Elena, MD, Ilaria Casetti, MD, Emanuela Sant 'Antonio, MD, Cesare Astori, MD, Chiara Milanesi, PhD, Marta Bellini, MD, Emanuela Boveri, MD, Virginia Ferretti, DR, Cristiana Pascutto, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 1592.

https://doi.org/10.1182/blood.V122.21.1592.1592

Published: 2013

NARROW

IPSS-M for Transplant Decision Making of Patients with Myelodysplastic Syndromes: A Retrospective Single-Center Study

Improving Prediction of Early Death in Acute Promyelocytic Leukemia: External Validation Study from Italian Single Center Experience

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)

Ropeginterferon Alfa-2b Versus Standard Therapy for Low-Risk Patients with Polycythemia Vera. Final Results of Low-PV Randomized Phase II Trial

Training and Validation Cohorts for Predicting the Impact of High Molecular Risk Mutations after Allogeneic Stem Cell Transplantation in Myelofibrosis

Second Versus First Wave of COVID-19 in Patients with MPN

The Interaction between IPSS Score and JAK2 Mutation Identifies Patients at Different Vascular Risk in Primary Myelofibrosis

Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms

Genomic Profiling of Blast Phase in Philadelphia-Negative Myeloproliferative Neoplasms

LNK mutations in familial myeloproliferative neoplasms

Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin

Clinical effect of driver mutations of JAK2 , CALR , or MPL in primary myelofibrosis

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

JAK2 (V617F)-Positive Essential Thrombocythemia and Polycythemia Vera Are Different Expressions Of a Genotypic/Phenotypic Continuum

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only